公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2002 | Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells | Chuang S.-E.; Yeh P.-Y.; YEN-SHEN LU ; Lai G.-M.; Liao C.-M.; Gao M.; ANN-LII CHENG | Biochemical Pharmacology | 161 | 138 | |
2013 | Benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride in the treatment of stage IV breast cancer patients | Dewi S; Larsen S; Srimuninnimit V; YEN-SHEN LU ; Manuaba T; Lindk?r-Jensen S. | Open Breast Cancer Journal | 7 | 0 | |
2016 | Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis | I-CHUN CHEN ; CHING-HUNG LIN ; I-SHIOW JAN ; ANN-LII CHENG ; YEN-SHEN LU | Journal of the Formosan Medical Association | 18 | 11 | |
2015 | Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy | YEN-SHEN LU ; WEI-WU CHEN ; CHING-HUNG LIN ; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; BANG-BIN CHEN ; Chao T.-C.; Huang S.-M.; CHIUN-SHENG HUANG ; TIFFANY TING-FANG SHIH ; ANN-LII CHENG ; Taiwan Breast Cancer Consortium | Clinical Cancer Research | 65 | 59 | |
2009 | Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway | Chen K.-F.; Yeh P.-Y.; CHIUN HSU ; CHIH-HUNG HSU ; YEN-SHEN LU ; Hsieh H.-P.; PEI-JER CHEN ; ANN-LII CHENG | Journal of Biological Chemistry | 89 | 84 | |
2020 | A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women | Lien, Guang-Wen; WU-SHIUN HSIEH ; WEN-HUNG KUO ; CHING-HUA KUO ; Huang, Ching-Chun; YUE-LIANG GUO; DWANG-YING CHANG ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN ; PAU-CHUNG CHEN | Environment International | 45 | 35 | |
2011 | Cisplatin as an active treatment in zoledronate-refractory hypercalcemia | PO-HAN LIN ; Chiu C.-F.; YEN-SHEN LU | Annals of Oncology | 1 | 1 | |
2022 | Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices | WEI-LI MA ; DWANG-YING CHANG ; CHING-HUNG LIN ; KAO-LANG LIU ; PO-CHIN LIANG ; HUANG-CHUN LIEN ; Hu, Chan-Chuan; Huang, Ling-Yun; Yeh, Yi-Chun; YEN-SHEN LU | The oncologist | 0 | 1 | |
2016 | Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer | I-CHUN CHEN ; Chang Y.-C.; YEN-SHEN LU ; KUEI-PIN CHUNG ; CHIUN-SHENG HUANG ; TZU-PIN LU ; WEN-HUNG KUO ; Wang M.-Y.; KUAN-TING KUO ; Wu P.-F.; Hsueh T.-H.; Shen C.-Y.; CHING-HUNG LIN ; ANN-LII CHENG | Scientific Reports | 18 | 17 | |
2013 | Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation | CHING-HUNG LIN ; Liu J.M.; YEN-SHEN LU ; Lan C.; Lee W.-C.; KUAN-TING KUO ; Wang C.-C.; DWANG-YING CHANG ; CHIUN-SHENG HUANG ; ANN-LII CHENG | Journal of Clinical Pathology | 13 | 14 | |
2010 | Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma | Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; SUNG-HSIN KUO ; CHIH-HUNG HSU ; YEN-SHEN LU ; ANN-LII CHENG | Cancer Letters | 19 | 19 | |
2019 | Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population | CHING-HUNG LIN ; Yap Y.S.; Lee K.-H.; Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; CHIUN-SHENG HUANG ; ANN-LII CHENG ; YEN-SHEN LU ; Asian Breast Cancer Cooperative Group | Journal of the National Cancer Institute | 81 | 73 | |
2013 | CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer | SUNG-HSIN KUO ; Yang, Shi-Yi; HUANG-CHUN LIEN ; Chiao Lo ; CHING-HUNG LIN ; YEN-SHEN LU ; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG | BioMed Research International | 9 | 9 | |
2008 | The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers | CHIUN-SHENG HUANG ; SUNG-HSIN KUO ; HUANG-CHUN LIEN ; Yang S.-Y.; You S.-L.; Shen C.-Y.; CHING-HUNG LIN ; YEN-SHEN LU ; KING-JEN CHANG | Oncologist | 19 | 18 | |
2018 | Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS | Chiu, Huai Hsuan; Liao, Hsiao Wei; YU-YUN SHAO ; YEN-SHEN LU ; CHING-HUNG LIN ; Tsai, I. Lin; CHING-HUA KUO | Analytica Chimica Acta | 47 | 45 | |
2017 | Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human plasma | Chiu H.-H.; Tsai I.-L.; YEN-SHEN LU ; CHING-HUNG LIN ; CHING-HUA KUO | Analytical and Bioanalytical Chemistry | 20 | 15 | |
2008 | Differential expression of glucocorticoid receptor in carcinomas of the human digestive system | HUANG-CHUN LIEN ; YEN-SHEN LU ; CHIA-TUNG SHUN ; Yao Y.-T.; Chang W.-C.; ANN-LII CHENG | Histopathology | 18 | 17 | |
2006 | Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms | HUANG-CHUN LIEN ; YEN-SHEN LU ; ANN-LII CHENG ; Chang W.-C.; YUNG-MING JENG ; Kuo Y.-H.; CHIUN-SHENG HUANG ; KING-JEN CHANG ; Yao Y.-T. | Journal of Pathology | 48 | 48 | |
2014 | Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance | HUANG-CHUN LIEN ; Lee Y.-H.; YUNG-MING JENG ; CHING-HUNG LIN ; YEN-SHEN LU ; Yao Y.-T. | Histopathology | 33 | 28 | |
2012 | Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transition | Wang C.-C.; JAU-YU LIAU ; YEN-SHEN LU ; Chen J.-W.; Yao Y.-T.; HUANG-CHUN LIEN | Histopathology | 40 | 36 | |